Growth hormone protects against radiotherapy-induced cell death

European Journal of Endocrinology

Volumn 147, Issue 4, 2002, Pages 535-541

  Madrid, Olga ^a   Varea, Silvia ^a   Sánchez Pérez, Isabel ^a   Gómez García, Lourdes ^a   De Miguel, Enrique ^a   Gómez de Segura, Ignacio A ^a   Perona, Rosario ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BLEOMYCIN; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; LUCIFERASE; VINCRISTINE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN IMMUNODEFICIENCY VIRUS; IONIZING RADIATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PROTECTION; RAT; REPORTER GENE;

EID: 0036773027     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470535     Document Type: Article

References (48)

1. Ward JF. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation, and reparability. Progress in Nucleic Acid Research and Molecular Biology 1988 35 95-125.
2. McMillan TJ. Residual DNA damage: what is left over and how does this determine cell fate? European Journal of Cancer 1992 28 267-269.
3. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Research 1994 54 2582-2590.
4. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, Ehleiter D et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001 293 293-297.
5. Howarth GS, Fraser R, Frisby CL, Schirmer MB & Yeoh EK. Effects of insulin-like growth factor-I administration on radiation enteritis in rats. Scandinavian Journal of Gastroenterology 1997 32 1118-1124.
6. Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Research 1998 58 933-939.
7. Okunieff P, Mester M, Wang J, Maddox T, Gong X, Tang D et al. In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiation Research 1998 150 204-211.
8. Houchen CW, George RJ, Sturmoski MA & Cohn SM. FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. American Journal of Physiology 1999 276 G249-G258.
9. Neta R, Stiefel SM, Finkelman F, Herrmann S & Ali N. IL-12 protects bone marrow from and sensitizes intestinal tract to ionizing radiation. Journal of Immunology 1994 153 4230-4237.
10. Neta R, Oppenheim JJ & Douches SD. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. Journal of Immunology 1988 140 108-111.
11. Redlich CA, Gao X, Rockwell S, Kelley M & Elias JA. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. Journal of Immunology 1996 157 1705-1710.
12. Potten CS. Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time. Stem Cells 1996 14 452-459.
13. Wu SG & Miyamoto T. Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiation Research 1990 123 112-115.
14. Potten CS, Booth D & Haley JD. Pretreatment with transforming growth factor beta-3 protects small intestinal stem cells against radiation damage in vivo. British Journal of Cancer 1997 75 1454-1459.
15. Fiebig HH, Dengler W & Hendriks HR. No evidence of tumor growth stimulation in human tumors in vitro following treatment with recombinant human growth hormone. Anticancer Drugs 2000 11 659-664.
16. Argetsinger LS & Carter Su C. Mechanism of signaling by growth hormone receptor. Physiological Reviews 1996 76 1089-1107.
17. Cheek DB & Hill DE. Effect of growth hormone on cell and somatic growth. In Handbook of Physiology. ch. 4, pp 159-185. Eds E Knobil & W Sawyer. Washington DC: American Physiological Society, 1974.
18. Neely EK & Rosenfeld RG. Use and abuse of human growth hormone. Annual Review of Medicine 1994 45 407-420.
19. Jiang ZM, He GZ, Zhang SY, Wang XR, Yang NF, Zhu Y et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Annals of Surgery 1989 210 513-524.
20. Slonim AE, Bulone L, Damore MB, Goldberg T, Wingertzahn MA & McKinley MJ. A preliminary study of growth hormone therapy for Crohn's disease. New England Journal of Medicine 2000 342 1633-1637.
21. Chen K, Nezu R, Inoue M, Wasa M, Iiboshi Y, Fukuzawa M et al. Beneficial effects of growth hormone combined with parenteral nutrition in the management of inflammatory bowel disease: an experimental study. Surgery 1997 121 212-218.
22. Byrne TA, Morrissey TB, Gatzen C, Benfell K, Nattakom TV, Scheltinga MR et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Annals of Surgery 1993 218 400-416.
23. Raff T & Germann G. Growth hormone in surgery-an assessment of current knowledge. Der Chirurg 1997 68 995-1003.
24. Gomez de Segura IA, Prieto I, Grande AG, Garcia A, Mendez J et al. Growth hormone reduces mortality and bacterial translocation in irradiated rats. Acta Oncologica 1998 37 179-185.
25. Perona R, Montaner S, Saniger L, Sanchez Perez I, Bravo R & Lacal JC. Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes and Development 1997 11 463-475.
26. Wood TJ, Sliva D, Lobie PE, Goullieux F, Mui AL, Groner B et al. Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter. Molecular and Cellular Endocrinology 1997 130 69-81.
27. Sanchez Perez I, Murguia JR & Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 1998 16 533-540.
28. Francis SM, Enerback S, Moller C, Enberg B & Norstedt G. A novel in vitro model for studying signal transduction and gene regulation via the growth hormone receptor. Molecular Endocrinology 1993 7 972-978.
29. Fiddes RJ, Brandon MR & Adams TE. Functional expression of an ovine growth hormone receptor in transfected Chinese hamster ovary cells. Molecular and Cellular Endocrinology 1992 86 37-47.
30. Pircher TJ, Flores Morales A, Mui AL, Saltiel AR, Norstedt G, Gustafsson JA et al. Mitogen-activated protein kinase kinase inhibition decreases growth hormone stimulated transcription mediated by STAT5. Molecular and Cellular Endocrinology 1997 133 169-176.
31. Moller C, Hansson A, Enberg B, Lobie PE & Norstedt G. Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. Journal of Biological Chemistry 1992 267 23403-23408.
32. Povirk LF & Austin MJ. Genotoxicity of bleomycin. Mutation Research 1991 257 127-143.
33. Goh EL, Pircher TJ & Lobie PE. Growth hormone promotion of tubulin polymerization stabilizes the microtubule network and protects against colchicine-induced apoptosis. Endocrinology 1998 139 4364-4372.
34. Parrizas M, Saltiel AR & LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. Journal of Biological Chemistry 1997 272 154-161.
35. Goh EL, Pircher TJ, Wood TJ, Norstedt G, Graichen R & Lobie PE. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription. Endocrinology 1997 138 3207-3215.
36. Dittmann KH, Gueven N, Mayer C & Rodemann HP The radioprotective effect of BBI is associated with the activation of DNA repair-relevant genes. International Journal of Radiation Biology 1998 74 225-230.
37. Thompson BJ, Shang CA & Waters MJ. Identification of genes induced by growth hormone in rat liver using cDNA arrays. Endocrinology 2000 141 4321-4324.
38. Zhan Q, Lord KA, Alamo I, Hollander MC, Carrier F, Ron D et al. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Molecular and Cellular Biology 1994 14 2361-2371.
39. Rothwell DG, Barzilay G, Gorman M, Morera S, Freemont P & Hickson ID. The structure and functions of the HAP1/Ref-1 protein. Oncology Research 1997 9 275-280.
40. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S & Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes and Development 1997 11 558-570.
41. Argetsinger LS & Carter Su C. Growth hormone signalling mechanisms: involvement of the tyrosine kinase JAK2. Hormone Research 1996 45 (Suppl 1) 22-24.
42. Love DW, Whatmore AJ, Clayton PE & Silva CM. Growth hormone stimulation of the mitogen-activated protein kinase pathway is cell type specific. Endocrinology 1998 139 1965-1971.
43. Argetsinger LS, Hsu GW, Myers MG, Billestrup N, White MF & Carter Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. Journal of Biological Chemistry 1995 270 14685-14692.
44. Argetsinger LS, Norstedt G, Billestrup N, White MF & Carter Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling. Journal of Biological Chemistry 1996 271 29415-29421.
45. Jeay S, Sonenshein GE, Kelly PA, Postel Vinay MC & Baixeras E. Growth hormone exerts antiapoptotic and proliferative effects through two different pathways involving nuclear factor-kappaB and phosphatidylinositol 3-kinase. Endocrinology 2001 142 147-156.
46. VanderKuur J, Allevato G, Billestrup, N, Norstedt G & Carter Su C. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. Journal of Biological Chemistry 1995 270 7587-7593.
47. Wang YD & Wood WI. Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. Molecular Endocrinology 1995 9 303-311.
48. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K & Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annual Review of Immunology 1995 13 369-398.